BAR-26423-04715
4 vaccinations
6 coded responses
44 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 681 / NE
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-08
Registered in v-safe
- 2021-03-08
- 2021-03-10
- 2021-03-11
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-04
- 2021-04-10
- 2021-04-17
- 2021-06-05
- 2021-09-04
-
2021-10-29
Dose 2 — Pfizer-BioNTech
-
2021-10-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-11-01
- 2021-11-02
-
2021-11-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body achesAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-12
-
2021-11-19
Survey response — day 21, dose 2MedDRA: Oropharyngeal pain, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend schoolFree text: Sore throat, fever, congestionMedDRA releases: 2024-11 · check-in free text available
- 2021-11-26
- 2021-12-03
-
2021-12-10
Survey response — day 42, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Rashes on arms, legs, and neckMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-01-28
-
2022-04-29
Survey response — 6 months, dose 2MedDRA: Rash — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RashesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-02
-
2022-05-07
Dose 3 — Pfizer-BioNTech
- 2022-06-05
- 2022-06-11
- 2022-06-18
- 2022-08-07
-
2022-10-07
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-07
-
2022-10-08
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-09
- 2022-10-10
-
2022-10-11
Survey response — days 1–6 daily, dose 4MedDRA: Respiratory tract congestion — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend schoolFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolFree text: Congestion; coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2023-01-06
-
2023-04-07
Survey response — 6 months, dose 4MedDRA: Sinusitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-07
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-04-12
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-29 | Pfizer-BioNTech | No |
| 3 | 2022-05-07 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | Flu |
Call center
3 call center cases
1 successful · 2 unsuccessful
Free text
Release 10 — day 21, dose 2
Symptoms: Sore throat, fever, congestion
Release 10 — day 42, dose 2
Symptoms: Rashes on arms, legs, and neck
Release 11 — 6 months, dose 2
Symptoms: Rashes
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Congestion
Systemic reaction (other): Congestion; cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release